PHARMACEUTICALS - Projects in Advanced Stage
Please click on the name of the product to see the details.
Formulation / Dosage : Tablet 2, 5, 10, 15, 20, 30 mg Therapeutical Use / ATC Code : Antipsychotic; N 5A Originator / Tradename : Otsuka/BMS/Abilify® Availability : UNDER DEVELOPMENT Dossier/Status Report for Aripiprazole
Formulation / Dosage : tablet 10 / 20 / 40 / 80 mg Therapeutical Use / ATC Code : Antihyperlipedemic; C 10A Originator / Tradename : Pfizer / Lipitor® Availability : UNDER DEVELOPMENT Dossier/Status Report for Atorvastatin
Formulation / Dosage : f.c. tablet 4 / 8 / 16 / 32 mg Therapeutical Use / ATC Code : Antihypertensive; C 9C Originator / Tradename : Astra Z. / Atacand® Availability : UNDER DEVELOPMENT Dossier/Status Report for Candesartan
Formulation / Dosage : f.c. tablet 4 / 8 / 16 / 32 mg Therapeutical Use / ATC Code : Antihypertensive; C 9C Originator / Tradename : Astra Z. / Atacand® Availability : UNDER DEVELOPMENT Dossier/Status Report for Candesartan/HCT
Formulation / Dosage : f.c. tablet 2.0 + 0.03 mg Therapeutical Use / ATC Code : Contraceptive; G 3A Originator / Tradename : Grünenthal / Belara® Availability : UNDER DEVELOPMENT Dossier/Status Report for Chlormadinone/EE
Formulation / Dosage : f.c. tablet 75 mg Therapeutical Use / ATC Code : Antithrombotic; B 1 Originator / Tradename : Sanofi / Plavix® Availability : UNDER DEVELOPMENT Dossier/Status Report for Clopidogrel
Formulation / Dosage : f.c. tablet 0.075 mg Therapeutical Use / ATC Code : Contraceptive; G 3A Originator / Tradename : Organon / Ceracette® Availability : UNDER DEVELOPMENT Dossier/Status Report for Desogestrel
Formulation / Dosage : tablet 25 mg Therapeutical Use / ATC Code : Anticancer; L 2B Originator / Tradename : Pfizer / Aromasin® Availability : UNDER DEVELOPMENT Dossier/Status Report for Exemestan
Formulation / Dosage : f.c. tablet 250/500/750/1000 mg oral solution 100 mg / ml Therapeutical Use / ATC Code : Antiepileptic; N 3A Originator / Tradename : UCB / Keppra® Availability : UNDER DEVELOPMENT Dossier/Status Report for Levetirazetam
Formulation / Dosage : f.c. tablet 10 mg chewable tablet 4 / 5 mg Therapeutical Use / ATC Code : Antiasthmatic; R 3J Originator / Tradename : MSD / Singulair® Availability : SOLD Dossier/Status Report for Montelukast
Formulation / Dosage : tablet 125 / 250 / 500 / 1000 µg Therapeutical Use / ATC Code : Anti-Parkinson; N 4B Originator / Tradename : B. Ingelheim / Sifrol® Availability : UNDER DEVELOPMENT Dossier/Status Report for Pramipexole
Formulation / Dosage : f.c. tablet 25/100/150/ 200/300 mg Therapeutical Use / ATC Code : Antipsychotic; N 5A Originator / Tradename : A. Zeneca / Seroquel® Availability : SOLD Dossier/Status Report for Quetiapine
Formulation / Dosage : f.c. tablet 80 / 160 mg Therapeutical Use / ATC Code : Antihypertensive; C 9D Originator / Tradename : Novartis / Diovan® Availability : SOLD Dossier/Status Report for Valsartan
Formulation / Dosage : f.c. tablet 80+12.5 / 160+12.5 mg Therapeutical Use / ATC Code : Antihypertensive; C 9D Originator / Tradename : Novartis / CoDiovan® Availability : SOLD Dossier/Status Report for Valsartan / HCT
